The relationship between FV Leiden and pulmonary embolism
作者： W Craig Hooper , Christine De Staercke
DOI: 10.1186/RR180
关键词: Venous thrombosis 、 Deep vein 、 Genetic risk factor 、 Disease entity 、 Surgery 、 Cardiology 、 Factor V 、 Internal medicine 、 Thrombosis 、 Pulmonary embolism 、 Medicine
摘要: Pulmonary embolism (PE) is one of the leading causes in-patient hospital deaths. As a consequence, identification hemostatic variables that could identify those at risk would be important in reducing mortality. It has previously been thought deep vein thrombosis and PE are single disease entity would, therefore, have same factors. This view changing, however, with realization prevalence FV Leiden, recognized genetic factor for thrombosis, may 'milder' PE. These observations suggest not only associated different set factors, but reflective clot structure.
biomedcentral.com
cdc.gov
springer.com
respiratory-research.com参考文章(24)
Ola Björgell, Paul E Nilsson, Jan-Åke Nilsson, Peter J Svensson, None, Location and extent of deep vein thrombosis in patients with and without FV:R 506Q mutation. Thrombosis and Haemostasis. ,vol. 83, pp. 648- 651 ,(2000) , 10.1055/S-0037-1613885
Rogier Bertina, Zandra Holmes, Caroline Spaargaren, Joannes van Krieken, Bert Manten, Jan Vandenbroucke, Pieter Reitsma, Factor V Leiden and Fatal Pulmonary Embolism Thrombosis and Haemostasis. ,vol. 79, pp. 511- 516 ,(1998) , 10.1055/S-0037-1614935
Margaret L. Gulley, Ruth E. Kohlmeier, Chong G. Cho, Robert C. Bux, Linda Guerra, Jennifer J. Rulon, Dale M. Selby, Prothrombin gene mutation uncommon in pulmonary embolism. Southern Medical Journal. ,vol. 93, pp. 1073- 1077 ,(2000)
Augueste Sturk, Steffen B. Rosen, Activated Protein C Resistance — A Major Risk Factor for Thrombosis European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. ,vol. 35, pp. 501- 516 ,(1997)
Bert Manten, Rudi G J Westendorp, Ted Koster, Pieter H Reitsma, Frits R Rosendaal, Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation. Thrombosis and Haemostasis. ,vol. 76, pp. 510- 513 ,(1996) , 10.1055/S-0038-1650613
SR Poort, FR Rosendaal, PH Reitsma, RM Bertina, A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. ,vol. 88, pp. 3698- 3703 ,(1996) , 10.1182/BLOOD.V88.10.3698.BLOODJOURNAL88103698
Franktien Turkstra, Rosa Karemaker, Philomeen MM Kuijer, Martin H Prins, Harry R Büller, None, Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different Thrombosis and Haemostasis. ,vol. 81, pp. 345- 348 ,(1999) , 10.1055/S-0037-1614474
Daniel T Price, Paul M Ridker, None, Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Annals of Internal Medicine. ,vol. 127, pp. 895- 903 ,(1997) , 10.7326/0003-4819-127-10-199711150-00007
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster, Frits R. Rosendaal, Richard J. Dirven, Hans de Ronde, Pieter A. van der Velden, Pieter H. Reitsma, Mutation in blood coagulation factor V associated with resistance to activated protein C Nature. ,vol. 369, pp. 64- 67 ,(1994) , 10.1038/369064A0
Martine Alhenc-Gelas, Martine Aiach, Anne-Marie Fischer, Hervé Sors, Jean Noel Fiessinger, Guy Meyer, Joseph Emmerich, Dominique Helley, Emmanuel Arnaud, Viviane Nicaud, Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. The American Journal of Medicine. ,vol. 110, pp. 12- 15 ,(2001) , 10.1016/S0002-9343(00)00653-7